AGIO AGIOS PHARMACEUTICALS INC
2026Q1 · CUSIP 00847X104 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
230
Δ holders QoQ
-7
Breadth percentile
Top 82%
Whale holders
120
Δ whales
0
Inst. holding value
$2.1B
New positions
35
Closed positions
42
Price momentum (1Q)
+1.4%
Put / Call
6/10
Breadth history (34 quarters)
Past Lit Events & Aftermath 5 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q2 | Top 14% | +23.0% | -24.5% |
| 2024Q1 | Top 19% | +32.4% | +56.6% |
| 2022Q3 | Top 10% | +2.0% | -3.8% |
| 2018Q2 | Top 15% | -16.1% | -24.0% |
| 2018Q1 | Top 9% | -11.7% | -25.9% |
Options Sentiment
Put holders
6
QoQ: -1
Call holders
10
QoQ: -3
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-7.26
EPS YoY
-162.9%
Revenue (TTM)
$0.1B
Revenue YoY
+78.3%
Net margin
—
ROE
-38.1%
Debt ratio
6.4%
FCF (TTM)
-$385M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.